Dr Paul Banford


Paul’s academic background is in biological and medical sciences. He graduated with a degree in Biochemistry and then undertook a PhD investigating the regulation of the respiratory burst in granulocytes.

Paul started working with HGF in 2010, having previously spent nearly 15 years with a large firm of patent attorneys, where he managed a specialist team of bioscience attorneys and built up an enviable reputation within the market place. He now assists HGF’s Life Sciences and Pharmaceuticals teams.

Paul’s practice covers a wide range of life science technology clients, ranging from start-ups to multinationals. He provides his clients with proactive, strategic advice and a significant proportion of his time is spent assisting start-ups (particularly academic spin-outs) to develop the type of patent portfolios that will attract private investment and satisfy the requirements of parties to initial public offerings on stock exchanges.

Paul also has a wealth of experience in reviewing patent estates as part of due diligence exercises. His due diligence work has included the preparation of reports in connection with listings on the London Stock Exchange (main market and AIM) and in connection with private investments and acquisitions. Paul also has significant experience in prosecuting life science related patent applications before the EPO (as well as in other major jurisdictions) and has enjoyed success in conducting oral proceedings before the EPO.